Home › Funds › TCG Crossover Management, LLC › IMVT

TCG Crossover Management, LLC position in IMVT

IMMUNOVANT INC · Health Care

TCG Crossover Management, LLC reported holding 4,457,988 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$171.8M, representing 4.13% of its reported portfolio and ranking #5 among its reported holdings. TCG Crossover Management, LLC has disclosed IMVT holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.46M sh
Reported value held$171.77M
Portfolio Weight4.13%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's IMVT position evolved

TCG Crossover Management, LLC first disclosed a stake in IMVT in Q3 2023 at 334,853 shares (US$12.9M). The position peaked in Q2 2026 at 4,457,988 shares, worth US$171.8M. Across 4 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 4,457,988 shares valued at US$171.8M. Notable position changes include a 168% increase in Q1 2026 (shares rose 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 334.85K $12.86M New
Q4 2025 1.66M $42.22M New
Q1 2026 4.46M $110.74M Add
Q2 2026 4.46M $171.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has TCG Crossover Management, LLC held IMVT?

TCG Crossover Management, LLC has disclosed IMVT holdings in 4 of the last 12 reported quarters, going back to Q3 2023.

What is TCG Crossover Management, LLC's current position in IMVT?

As of Q2 2026, TCG Crossover Management, LLC holds 4.46M shares of IMVT (IMMUNOVANT INC), valued at $171.77M, representing 4.13% of its reported portfolio and ranking #5.

Has TCG Crossover Management, LLC been buying or selling IMVT?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in IMVT. The position peaked in Q2 2026 at 4.46M shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.